HomeVVOS • NASDAQ
Vivos Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 3.70M | 13.85% |
Operating expense | 4.90M | -21.20% |
Net income | -2.83M | 33.62% |
Net profit margin | -76.45 | 41.70% |
Earnings per share | -0.28 | 89.84% |
EBITDA | -2.66M | 33.18% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.26M | 281.01% |
Total assets | 15.28M | 42.44% |
Total liabilities | 7.33M | -28.97% |
Total equity | 7.95M | — |
Shares outstanding | 5.89M | — |
Price to book | 2.25 | — |
Return on assets | -45.80% | — |
Return on capital | -74.73% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.83M | 33.62% |
Cash from operations | -2.94M | -6.99% |
Cash from investing | -165.00K | 0.00% |
Cash from financing | 3.05M | -14.41% |
Net change in cash | -51.00K | -107.79% |
Free cash flow | -1.99M | 33.51% |
Previous close
$3.04
Day range
$2.90 - $3.18
Year range
$1.91 - $6.28
Market cap
17.48M USD
Avg Volume
81.80K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2016
Headquarters
Website
Employees
109
